Gurjyot Gury K. Doshi, M.D.

Gurjyot "Gury" K. Doshi, M.D., is board certified in hematology and medical oncology. Dr. Doshi treats various cancers, including breast, lung, and colon cancer, as well as other cancers. Her special interest is in treatment of genitourinary tumors, prostate, kidney, and bladder cancers. In addition, she treats benign and malignant blood disorders. Dr. Gury Doshi is associate chair of the genitourinary committee of US Oncology Research. She joined the genitourinary committee program in 2012 and has quickly risen as a leader serving as US Oncology Research principal investigator for multiple studies and as a top enroller to clinical trials annually. Her research publications include a review on sequencing therapies in metastatic renal cell carcinoma and the use of morphoproteomic analysis to determine selection of therapy in kidney cancer. Prior to joining Texas Oncology in 2010, Dr. Doshi was an assistant professor in the Division of Oncology at The University of Texas in the Texas Medical Center.